Atlas Trials

A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

Clinical trial NCT03710486 · COMPLETED

Trial details

NCT number
NCT03710486
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Colitis, UlcerativeCrohn Disease
Start date
2019-02-19
Primary completion
2021-08-23
Enrollment
409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.